Dr., Italian and European Patent Attorney, Professional Representative in Community Design matters before the EUIPO. Rebecca graduated in Biological Sciences from the University of Catania and completed a postgraduate specialization in Medical Genetics at the University of Catania.
Rebecca Rimini
- Languages:Italian native speaker, fluent in English and Swedish
- Office:Turin
- Area of competence:Patents
Work experience
Rebecca worked for many years as a researcher, both in academy and industry (DIBIT, San Raffaele Biomedical Science Park in Milan; GlaxoSmithKline in Verona; Royal Institute of Technology, KTH, in Stockholm), where she developed a very strong scientific knowledge and broad technical expertise relating to many different aspects within the fields of life sciences, diagnostics and pharmaceuticals. She also acquired a deep knowledge of the various phases of drug development processes.
Before joining Jacobacci & Partners in 2018, Rebecca worked for eight years as an IP specialist in a multinational company based in Italy operating in the field of diagnostics, and she handled patent work also for the company’s subsidiaries in the United States, Germany and Ireland.
Professional focus
Rebecca has extensive experience on drafting and prosecuting Italian, European and International patent applications. During her experience as in-house IP specialist, she has been involved in numerous product development projects involving, in particular, patent landscape and Freedom-to-Operate (FTO) searches and analysis as well as in due diligence projects. She has also regularly provided infringement and validity assessments.
Areas of expertise
Rebecca’s primary focus is on biotechnological, pharmaceutical and chemical matters. She has extensive experience in drug development, diagnostic assays and biomarkers discovery, relating to variuos clinical areas such as infectious diseases and neurologic disorders. Her technical expertise is very broad, covering immunological and nucleic acid techniques, antibodies, recombinant proteins and peptides, antisense oligonucleotides, platforms for transcriptomic and proteomic studies and cellular biology.